Similar articles for PMID: 29280473

Year	Number of Results
1999	1
2002	1
2004	1
2005	2
2007	5
2008	4
2009	9
2010	7
2011	9
2012	6
2013	1
2014	7
2015	5
2016	8
2017	12
2018	8
2019	10
2020	5
2021	2
2022	3
2023	5
2024	0

1

The Safety of Low-Molecular-Weight Heparin During and After Pregnancy.

Lu E, Shatzel JJ, Salati J, DeLoughery TG. Lu E, et al. Obstet Gynecol Surv. 2017 Dec;72(12):721-729. doi: 10.1097/OGX.0000000000000505. Obstet Gynecol Surv. 2017. PMID: 29280473 Review.

2

Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J. Bates SM, et al. Chest. 2008 Jun;133(6 Suppl):844S-886S. doi: 10.1378/chest.08-0761. Chest. 2008. PMID: 18574280

3

Risk of venous thromboembolism in pregnant women with essential thrombocythemia: a systematic review and meta-analysis.

Skeith L, Carrier M, Robinson SE, Alimam S, Rodger MA. Skeith L, et al. Blood. 2017 Feb 23;129(8):934-939. doi: 10.1182/blood-2016-09-728006. Epub 2017 Jan 3. Blood. 2017. PMID: 28049641 Free article. Review.

4

Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses.

Bleker SM, Buchmüller A, Chauleur C, Ní Áinle F, Donnelly J, Verhamme P, Jacobsen AF, Ganzevoort W, Prins M, Beyer-Westendorf J, DeSancho M, Konstantinides S, Pabinger I, Rodger M, Decousus H, Middeldorp S. Bleker SM, et al. Thromb Res. 2016 Aug;144:62-8. doi: 10.1016/j.thromres.2016.06.001. Epub 2016 Jun 3. Thromb Res. 2016. PMID: 27289488 Clinical Trial.

5

The incidence and risk factors of recurrent venous thromboembolism during pregnancy.

Galambosi PJ, Ulander VM, Kaaja RJ. Galambosi PJ, et al. Thromb Res. 2014 Aug;134(2):240-5. doi: 10.1016/j.thromres.2014.04.026. Epub 2014 May 2. Thromb Res. 2014. PMID: 24835671

6

[Thromboprophylaxis with low-molecular-weight heparin insufficient in high-risk pregnancy].

Roeters van Lennep JE, Meijer E, Klumper FJ, Middeldorp JM, Bloemenkamp KW, Middeldorp S. Roeters van Lennep JE, et al. Ned Tijdschr Geneeskd. 2011;155:A3433. Ned Tijdschr Geneeskd. 2011. PMID: 21527059 Dutch.

7

Prevention and management of venous thromboembolism in pregnancy: cutting through the practice variation.

Skeith L. Skeith L. Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):559-569. doi: 10.1182/hematology.2021000291. Hematology Am Soc Hematol Educ Program. 2021. PMID: 34889418 Free PMC article.

8

Prophylaxis with low-dose low-molecular-weight heparin during pregnancy and postpartum: is it effective?

Roeters van Lennep JE, Meijer E, Klumper FJ, Middeldorp JM, Bloemenkamp KW, Middeldorp S. Roeters van Lennep JE, et al. J Thromb Haemost. 2011 Mar;9(3):473-80. doi: 10.1111/j.1538-7836.2011.04186.x. J Thromb Haemost. 2011. PMID: 21232006 Free article.

9

Use of the Delphi method to facilitate antithrombotics prescription during pregnancy.

Chauleur C, Gris JC, Laporte S, Rancon F, Varlet MN, Decousus H, Mismetti P; STRATHEGE Group. Chauleur C, et al. Thromb Res. 2010 Aug;126(2):88-92. doi: 10.1016/j.thromres.2010.01.012. Epub 2010 Feb 13. Thromb Res. 2010. PMID: 20153880

10

Women's values and preferences and health state valuations for thromboprophylaxis during pregnancy: A cross-sectional interview.

Bates SM, Alonso-Coello P, Tikkinen KA, Ebrahim S, Lopes LC, McDonald SD, Zhou Q, Akl EA, Neumann I, Jacobsen AF, Zhang Y, Santamaría A, Annichino-Bizzacchi JM, Sandset PM, Bitar W, Eckman MH, Guyatt GH. Bates SM, et al. Thromb Res. 2016 Apr;140:22-9. doi: 10.1016/j.thromres.2015.12.015. Thromb Res. 2016. PMID: 27500301

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

100 results

Results by year